“…Functional studies implicated altered expression of the glucose transporter encoded by SLC2A3 (GLUT3) as a cause of cardiovascular, neuronal, and immunological abnormalities in affected CNV carriers. SLC2A3 is expressed in the brain, pharyngeal arches, and left ventricular outflow tract during development, and knockdown of the mouse and zebrafish orthologs causes early embryonic lethality [Ganguly et al, ; Carayannopoulos et al, ]. Mutation of SLC2A10 , a paralog of SLC2A3 , causes arterial tortuosity syndrome, a developmental disorder characterized by congenital malformations, aneurysms, and dissections of the aorta and other arteries [Cheng et al, ].…”